ELIZABETH PAK: Open Payments
NPI 1619528833 · FORT WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 32 payments from 6 companies in 2025. Trend: 2023 $252 · 2024 $381 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $255 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $231 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, Auvelity, REXULTI, COBENFY.
Industry payments across PA — which companies pay providers there.
